Monthly Archives: January 2019

Genprex to Present at NobleConXV in Fort Lauderdale, Florida

Noble Capital Markets' Fifteenth Annual Investor / Equity Conference

Read More

Genprex to Present at Biotech Showcase™ 2019 in San Francisco

AUSTIN, Texas & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 3, 2019-- Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, today announced that it will present at Biotech Showcase™ 2019.

Read More